Comparison of Fascial Iliac Compartment Block and Quadratus Lumborum Block for Hip Surgery

Transmuscular Quadratus Lumborum Block Versus Supra-inguinal Fascial Iliac Compartment Block for Total Hip Arthroplasty: a Randomized, Prospective Study

Status

UNKNOWN

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT04827121

Enrollment

100

Registered

2021-04-01

Start date

2021-05-31

Completion date

2022-06-01

Last updated

2021-06-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Analgesia

Keywords

Ultrasound, Total hip arthroplasty, Nerve block

Brief summary

Iliac fascia block has a long history of analgesia in patients with hip fractures. A large number of clinical studies have confirmed its efficacy, and there are also randomized controlled studies supporting its effectiveness in analgesia after total hip replacement surgery.Quadratus lumborum block is a new block technique developed in last decade, and there are also a few randomized controlled studies supporting its effectiveness in postoperative analgesia for total hip replacement.The purpose of the present study was to find out whether these two different approaches of fascial compartment block have similar effects on postoperative analgesia after total hip replacement.

Interventions

PROCEDUREQuadratus lumborum block

Patients will recieve transmuscular approach of quadratus lumborum block under ultrasound guidance with 30 ml of 0.5 percent ropivacaine.

PROCEDUREFascial iliac compartment block

Patients will recieve supra-inguinal approach of fascial iliac compartment block under ultrasound guidance with 30 ml of 0.5 percent ropivacaine.

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

SUPPORTIVE_CARE

Masking

DOUBLE (Subject, Outcomes Assessor)

Eligibility

Sex/Gender

ALL

Age

18 Years to 80 Years

Healthy volunteers

Inclusion criteria

* ASA class 1-3 * BMI between 20-36kg/m\^2 * Scheduled to undergo total hip replacement

Exclusion criteria

* A history of chronic opioids or steroid consumption * Coagulapathy or anticoagulation * Pregnancy * Allergic to local anesthetics Neurological dysfunction

Design outcomes

Primary

Measure	Time frame	Description
Cumulative opioids consumption at 24 hours	Within 24 hours	Cumulative consumption of sufentanil from PCA device at 24 hours after surgery

Secondary

Measure	Time frame	Description
NRS score with movement at 6,12,and 24 hours	at 6,12,and 24 hours	Patients' NRS score with movement at 6,12,and 24 hours after surgery

Countries

China

Contacts

Primary ContactShuguang Yang, M.D.

yangsuperpro@163.com+86-150-7107-8161

Backup ContactWei Mei, PhD

wmei@hust.edu.cn+86-130-0616-2508

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026